In this work, with the aim to combine the CD44-targeting ability of HA and the redox-responsivity of cystamine (cys), we develop a nanoparticle system (FNPs) via ionic complexation at physiological pH of cysHSA derivative and HA for doxorubicin (DOX) vectorization in breast cancer cell lines. This evidence concerns the gene CD44 and breast carcinoma.